1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. PRETERM BIRTH AND PROM TESTING MARKET BY PRETERM BIRTH TESTS
5.1. Introduction
5.2. Pelvic exam
5.3. Ultrasound
5.4. Others
6. PRETERM BIRTH AND PROM TESTING MARKET BY PROM TESTS
6.1. Introduction
6.2. Nitrazine Test
6.3. Ferning Test
6.4. Others
7. PRETERM BIRTH AND PROM TESTING MARKET BY END-USER
7.1. Introduction
7.2. Diagnostic Laboratories
7.3. Hospitals
7.4. Others
8. PRETERM BIRTH AND PROM TESTING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Hologic, Inc
10.2. Abbott
10.3. Sera Prognostics Inc.
10.4. CooperSurgical Inc.
10.5. IQ Products
10.6. Qiagen N.V.
10.7. BHR Pharmaceuticals
10.8. NX Prenatal, Inc.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES